Pharmaron Beijing Co., Ltd.

¥45.89As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300759Healthcare
Country China
PE (Fwd) •••
TSR 8Y CAGR 29.25%
Div yield 0.44%
ROE 10.37%
Biotechnology
Beta (5Y) 0.69
PE TTM 47.15
TSR TTM 37.84%
Mkt cap ¥76.68B
ROIC 8.44%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥48
3.58%
(77.15%)
Sell 0|4|1|12|11
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.73
0.81
0.79
0.78
12.56%
24.60%
16.37%
18.54%
Revenue¥B
4.178
4.306
4.336
4.291
10.41%
10.28%
5.04%
1.85%
Peers (US$11.49B)
Cap (US$)
PE
11.43B
66.21x
Capital
TTM
5Y
10Y
Leveragex
0.367
(0.192)
(0.132)
EBIT/Intx
0.964
0.149
0.170
Own earn%
117.83
15.84
13.05
Sh yield%
33.43
37.01
33.32
Owners
Insiders/Inst%
14.31
58.15
Short interest%
2.51
SBC / revenue%
4.10
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
14–22
$1 testx
—
Incr. ROIC%
4